🔎 Trials Near Me

Home › Soft Tissue Sarcoma › Florida › Miami

Soft Tissue Sarcoma clinical trials in Miami, FL

6 studies for Soft Tissue Sarcoma are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

RecruitingPhase 1/2
  • University of Miami - Sylvester Comprehensive Cancer Center, Miami
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06797999

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

RecruitingPhase 1/2
  • Sylvester Comprehensive Cancer Center, Miami
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05732831

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

RecruitingPhase 1
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT05711615

Lead-212 PSV359 Therapy for Patients With Solid Tumors

RecruitingPhase 1/2
  • University of Miami, Miami
  • Biogenix, Miami
Ages 18 to 90 · All sexes · Updated Jul 6, 2026 · NCT06710756

Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patients

Recruiting
  • University of Miami, Miami
Ages 12 to 39 · All sexes · Updated Feb 18, 2026 · NCT07359911

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

RecruitingObservational studyHealthy volunteers welcome
  • Miami Cancer Institute, Miami
Ages 40 and older · All sexes · Updated Jan 20, 2026 · NCT05366881

About Soft Tissue Sarcoma

Soft tissue sarcoma refers to cancer that begins in the muscle, fat, vessels or tendons. It can cause a lump or swelling. See which treatments are available

More about Soft Tissue Sarcoma on MedlinePlus

Soft Tissue Sarcoma trials in other cities

Other studies in Miami

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.